Arax Advisory Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.8K | Buy |
333
+118
| +55% | +$14.8K | ﹤0.01% | 1325 |
|
|
2025
Q1 | $29.4K | Hold |
215
| – | – | ﹤0.01% | 1144 |
|
|
2024
Q4 | $32.9K | Buy |
+215
| New | +$32.9K | ﹤0.01% | 1022 |
|
|
2024
Q3 | – | Sell |
-20
| Closed | -$4.64K | – | 2626 |
|
|
2024
Q2 | $4.64K | Sell |
20
-5
| -20% | -$1.16K | ﹤0.01% | 1626 |
|
|
2024
Q1 | $5.39K | Buy |
25
+20
| +400% | +$4.31K | ﹤0.01% | 886 |
|
|
2023
Q4 | $1.29K | Hold |
5
| – | – | ﹤0.01% | 1092 |
|
|
2023
Q3 | $1.29K | Hold |
5
| – | – | ﹤0.01% | 1087 |
|
|
2023
Q2 | $1.43K | Hold |
5
| – | – | ﹤0.01% | 1046 |
|
|
2023
Q1 | $1.39K | Hold |
5
| – | – | ﹤0.01% | 1042 |
|
|
2022
Q4 | $1.39K | Hold |
5
| – | – | ﹤0.01% | 1007 |
|
|
2022
Q3 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 1040 |
|
|
2020
Q4 | – | Sell |
-5
| Closed | -$1K | – | 732 |
|
|
2020
Q3 | $1K | Hold |
5
| – | – | ﹤0.01% | 657 |
|
|
2020
Q2 | $1K | Hold |
5
| – | – | ﹤0.01% | 644 |
|
|
2020
Q1 | $2K | Hold |
5
| – | – | ﹤0.01% | 621 |
|
|
2019
Q4 | $1K | Hold |
5
| – | – | ﹤0.01% | 561 |
|
|
2019
Q3 | $1K | Hold |
5
| – | – | ﹤0.01% | 563 |
|
|
2019
Q2 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 567 |
|
|
2018
Q4 | $2K | Sell |
5
-12
| -71% | -$4.8K | ﹤0.01% | 524 |
|
|
2018
Q3 | $6K | Sell |
17
-111
| -87% | -$39.2K | ﹤0.01% | 511 |
|
|
2018
Q2 | $37K | Buy |
128
+22
| +21% | +$6.36K | 0.02% | 241 |
|
|
2018
Q1 | $29K | Sell |
106
-60
| -36% | -$16.4K | 0.02% | 251 |
|
|
2017
Q4 | $52K | Sell |
166
-5
| -3% | -$1.57K | 0.02% | 207 |
|
|
2017
Q3 | $53K | Buy |
171
+15
| +10% | +$4.65K | 0.03% | 205 |
|
|
2017
Q2 | $42K | Sell |
156
-32
| -17% | -$8.62K | 0.02% | 244 |
|
|
2017
Q1 | $51K | Buy |
188
+78
| +71% | +$21.2K | 0.02% | 201 |
|
|
2016
Q4 | $31K | Buy |
+110
| New | +$31K | 0.02% | 215 |
|